Dementia, Epilepsy, and Death Trends: England & Wales (2014-2023)
Table of Contents
Published October 4,2025
Rising Mortality: A Decade of Trends
Analysis of national death registration data from 2014 to 2023 reveals important trends in mortality related to dementia,alzheimer’s disease,and epilepsy in England and Wales.Teh data highlights a consistent increase in deaths associated with these conditions over the ten-year period, signaling growing public health challenges.
Dementia and Alzheimer’s disease: A Notable Increase
Deaths involving dementia and Alzheimer’s disease demonstrated a ample upward trajectory. In 2023, dementia and Alzheimer’s were listed as underlying or contributory causes on death certificates for a substantially higher number of individuals compared to 2014, reflecting both an aging population and potential improvements in diagnosis.This increase underscores the urgent need for continued research into prevention, treatment, and care for these debilitating conditions.
While deaths related to epilepsy showed more fluctuation than those linked to dementia, an overall increase was observed across the decade. The data suggests a complex interplay of factors influencing epilepsy-related mortality, including access to care, seizure control, and potential underlying health conditions. Further investigation is needed to understand the specific drivers behind these trends and identify opportunities for improved outcomes.
Implications for Healthcare Services
These mortality trends have significant implications for healthcare planning and resource allocation. The rising number of deaths associated with dementia and Alzheimer’s disease necessitates increased investment in specialist dementia care, palliative care services, and support for caregivers. Similarly, addressing the factors contributing to epilepsy-related deaths requires a focus on improving epilepsy diagnosis, treatment adherence, and access to specialized neurological care.
Proactive strategies,including early detection programs,enhanced public awareness campaigns,and integrated care pathways,are crucial to mitigate the impact of these conditions and improve the quality of life for individuals and families affected by dementia,Alzheimer’s disease,and epilepsy.